Citius Pharmaceuticals Inc vs TKO Group Holdings Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while TKO Group Holdings Inc trades at $194.36 (market cap $14.24B). The key difference: TKO Group Holdings Inc is far larger — about 711.6× Citius Pharmaceuticals Inc's market cap, and TKO Group Holdings Inc pays a 1.6% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | TKO | |
|---|---|---|
Market Cap | $20.01M | $14.24B |
Sector | Health | Technology |
52-Week High | $1.82 | $224.96 |
52-Week Low | $0.48 | $176.49 |
Enterprise Value | $16.23M | $18.60B |
Dividend Yield | — | 1.6% |
Trailing returns across standard periods
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →